Vanden Wyngaert Karsten, Suykens Janne, Kelly Deirdre, Goncalves Isabel, Thomsen Ena Lindhart, Willemse Jose, Mariño Zoe, Madaleno João, Day Jemma, Samyn Marianne, Ali Mohamed, Jørgensen Marianne Hørby, Goossens Eva, De Munter Johan, Staa Anneloes Van, Wray Jo, Protopapa Panayiota, Lohse Ansgar, De Bruyne Ruth
Department of Internal Medicine and Pediatrics, Faculty of Health Sciences, Ghent University, Ghent, Belgium.
Centre for Nursing Excellence, Ghent University Hospital, Ghent, Belgium.
JHEP Rep. 2025 Mar 26;7(6):101403. doi: 10.1016/j.jhepr.2025.101403. eCollection 2025 Jun.
BACKGROUND & AIMS: The transfer journey from pediatric to adult care services of young people with rare liver diseases poses significant challenges and is an underexplored research area. This study examined the critical aspects of, and opportunities for, transfer journey management for these young people in Europe.
In total, 72 individuals, representing 13 countries, participated in an omnistakeholder workshop on 17-18 March 2023. A standardized workshop methodology was used to discuss critical aspects and actions over nine focus sessions. The themes of these sessions were identified by engaging with healthcare providers, young people, and parents. Results ( aspects receiving >25% of the votes) were ranked based on importance and validated by the European Reference Network of Hepatological Diseases (ERN RARE-LIVER) youth panel.
Our findings revealed that the critical aspects of transfer journey management predominantly revolved around the transfer itself. Most of the critical aspects and actions were related to improving communication ( allocating sufficient time, 81% of votes; giving consistent information, 43%; and discussing communication preferences, 100%), relational continuity ( appointing a transition person to liaison between stakeholders, 79%), and management continuity ( using a transfer document, 60%). Our results also underscored the importance of peer mentorship programs (100%), informing young people about the transfer process (85%), and implementing joint consultations (93%).
Current literature and guidelines on 'transition' might not fully address real-world challenges in rare liver diseases, particularly those concerning maintaining continuity of care during the actual transfer process. Future research should examine the effectiveness of strategies aimed at enhancing communication and continuity of care throughout the transfer journey, focusing on stakeholder experience.
This international omnistakeholder workshop explored challenges and opportunities in managing transfer journeys for young people with rare liver diseases. By emphasizing practical implications (leading to actions), it provides a benchmark for improving transfer journeys worldwide, applicable to not only rare liver diseases, but possibly also common liver or other rare diseases. Our findings underscore the fundamental importance of the transfer itself in maintaining continuity of care. The critical aspects identified center around informative, relational, and management continuity of care and have been transformed into minimal criteria.
患有罕见肝脏疾病的年轻人从儿科护理服务向成人护理服务的过渡过程面临重大挑战,且是一个未得到充分探索的研究领域。本研究探讨了欧洲这些年轻人过渡过程管理的关键方面和机会。
来自13个国家的72人参加了2023年3月17 - 18日举行的多利益相关方研讨会。采用标准化的研讨会方法,在九个重点会议上讨论关键方面和行动。这些会议的主题是通过与医疗服务提供者、年轻人及其父母交流确定的。结果(获得超过25%选票的方面)根据重要性进行排序,并由欧洲肝病参考网络(ERN RARE-LIVER)青年小组进行验证。
我们的研究结果表明,过渡过程管理的关键方面主要围绕过渡本身。大多数关键方面和行动与改善沟通(分配足够时间,81%的选票;提供一致信息,43%;讨论沟通偏好,100%)、关系连续性(指定一名过渡人员在利益相关方之间进行联络,79%)和管理连续性(使用过渡文件,60%)有关。我们的结果还强调了同伴指导计划(100%)、告知年轻人过渡过程(85%)以及开展联合咨询(93%)的重要性。
当前关于“过渡”的文献和指南可能无法完全解决罕见肝脏疾病的实际挑战,特别是那些在实际过渡过程中涉及维持护理连续性的问题。未来的研究应考察旨在增强整个过渡过程中沟通和护理连续性的策略的有效性,重点关注利益相关方的体验。
本次国际多利益相关方研讨会探讨了患有罕见肝脏疾病的年轻人过渡过程管理中的挑战和机会。通过强调实际影响(导致行动),它为改善全球范围内的过渡过程提供了一个基准,不仅适用于罕见肝脏疾病,也可能适用于常见肝脏疾病或其他罕见疾病。我们的研究结果强调了过渡本身在维持护理连续性方面的根本重要性。确定的关键方面围绕护理的信息性、关系性和管理连续性,并已转化为最低标准。